Header Logo

SHIAO-PEI WEATHERS

TitleAssistant Professor
InstitutionMD Anderson
DepartmentNeuro-Oncology
Address1400 Holcombe Blvd
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Majd NK, Vo HH, Moran CA, Weathers SP, Song IW, Williford GL, Rodon J, Fu S, Tsimberidou AM. Metastatic extraneural glioblastoma diagnosed with molecular testing. Oncologist. 2024 Sep 06; 29(9):811-816. PMID: 38837109; PMCID: PMC11379637.
      Citations:    Fields:    Translation:Humans
    2. Whisenant M, Snyder S, Weathers SP, Bruera E, Milbury K. Self and proxy symptom reporting in glioma patient-caregiver dyads: the role of psychosocial function in rating accuracy. J Patient Rep Outcomes. 2024 Jul 17; 8(1):74. PMID: 39017959; PMCID: PMC11255136.
      Citations:    Fields:    Translation:Humans
    3. Lam K, Leung CH, Soomro Z, Wathoo C, Weathers SP. Perspectives from neuro-oncology providers on patient access to electronic records: a survey study. CNS Oncol. 2024 Jun 06; 13(1):2352414. PMID: 38869443; PMCID: PMC11152585.
      Citations:    Fields:    Translation:Humans
    4. Cho D, Roth M, Peterson SK, Jennings K, Kim S, Weathers SP, Ahmed S, Livingston JA, Barcenas C, You YN, Milbury K. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study. JMIR Res Protoc. 2024 Apr 23; 13:e53307. PMID: 38652520; PMCID: PMC11077407.
      Citations: 1     Translation:Humans
    5. Gregory TA, Knight SR, Aaroe AE, Highsmith KN, Janatpour ZC, O'Brien BJ, Majd NK, Loghin ME, Patel CB, Weathers SP, Puduvalli VK, Kamiya-Matsuoka C. Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control study. Neurooncol Pract. 2024 Aug; 11(4):475-483. PMID: 39006516; PMCID: PMC11241387.
      Citations: 2     
    6. Nelson BE, Roszik J, Ahmed J, Barretto CMN, Nardo M, Campbell E, Johnson AM, Piha-Paul SA, Oliva ICG, Weathers SP, Cabanillas M, Javle M, Meric-Bernstam F, Subbiah V. RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study. Mol Cancer. 2024 03 26; 23(1):64. PMID: 38532456; PMCID: PMC10964523.
      Citations:    Fields:    Translation:Humans
    7. Whisenant M, Weathers SP, Li Y, Aldrich E, Ownby K, Thomas J, Ngo-Huang A, Bruera E, Milbury K. Simulation-based caregiving skills training for family members of high-grade glioma patients. Neurooncol Pract. 2024 Aug; 11(4):432-440. PMID: 39006525; PMCID: PMC11241359.
      Citations:    
    8. Gubbiotti MA, Weinberg JS, Weathers SP, Dasgupta P, Tom MC, Aldape K, Quezado M, Abdullaev Z, Huse JT, Ballester LY. An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1 mutation. J Neuropathol Exp Neurol. 2024 01 19; 83(2):139-141. PMID: 38164987; PMCID: PMC11032702.
      Citations:    Fields:    Translation:Humans
    9. Nelson BE, Reddy NK, Huse JT, Amini B, Nardo M, Gouda M, Weathers SP, Subbiah V. Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma. NPJ Precis Oncol. 2023 May 25; 7(1):47. PMID: 37231247; PMCID: PMC10212928.
      Citations: 1     
    10. Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NK. Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad032. PMID: 37114244; PMCID: PMC10129387.
      Citations:    
    11. Milbury K, Whisenant M, Weathers SP, Malliaha S, Snyder S, Jackson N, Li J, Li Y, Silva RF, Shih YT, Cohen L. Dyadic versus individual delivery of a yoga program for family caregivers of glioma patients undergoing radiotherapy: Results of a 3-arm randomized controlled trial. Cancer Med. 2023 03; 12(6):7567-7579. PMID: 36468605; PMCID: PMC10067051.
      Citations:    Fields:    Translation:Humans
    12. Groot J, Ott M, Wei J, Kassab C, Fang D, O'Brien B, Weathers SP, Matsouka CK, Majd NK, Harrison RA, Fuller GN, Huse JT, Long JP, Sawaya R, Rao G, MacDonald TJ, Priebe W, Najem H, DeCuypere M, Heimberger AB. A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma. CNS Oncol. 2022 06 01; 11(2):CNS87. PMID: 35575067; PMCID: PMC9134932.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    13. Capone S, Ketonen L, Weathers SP, Subbiah V. Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1N546K Mutation. JCO Precis Oncol. 2022 04; 6:e2100371. PMID: 35507888; PMCID: PMC9200395.
      Citations:    Fields:    Translation:Humans
    14. Rogers JL, De La Cruz Minyety J, Vera E, Acquaye AA, Weinberg JS, Armstrong TS, Weathers SS, Pay?n SS. Assessing mobility in primary brain tumor patients: A descriptive feasibility study using two established mobility tests. Neurooncol Pract. 2022 May; 9(3):219-228. PMID: 35601968; PMCID: PMC9113321.
      Citations:    
    15. Kroll JL, Kim S, Cho D, Weathers SP, Chen AB, Smith G, Bruera E, Milbury K. Financial distress and its associated burden in couples coping with an advanced cancer. Support Care Cancer. 2022 May; 30(5):4485-4495. PMID: 35112209.
      Citations:    Fields:    Translation:Humans
    16. Harrison RA, Ou A, Naqvi SMAA, Naqvi SM, Weathers SS, O'Brien BJ, de Groot JF, Bruera E. Aggressiveness of care at end of life in patients with high-grade glioma. Cancer Med. 2021 12; 10(23):8387-8394. PMID: 34755486; PMCID: PMC8633215.
      Citations: 2     Fields:    Translation:Humans
    17. Weathers SP, Rood-Breithaupt J, de Groot J, Thomas G, Manfrini M, Penas-Prado M, Puduvalli VK, Zwingelstein C, Yung WKA. Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab141. PMID: 34693288; PMCID: PMC8528265.
      Citations:    
    18. Majd NK, Mastall M, Lin H, Dibaj SS, Hess KR, Yuan Y, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harriso RA, De Groo JF, Puduvalli VK, Penas-Prado M, Garcia MM. Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab079. PMID: 34377987; PMCID: PMC8350154.
      Citations: 1     
    19. Wang M, Jain P, Chi TL, Chen SE, Heimberger A, Weathers SP, Zheng L, Rao AV, Rossi JM. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. J Immunother Cancer. 2020 10; 8(2). PMID: 33067318; PMCID: PMC7570235.
      Citations: 2     Fields:    Translation:Humans
    20. Sen S, Tanaka R, Khatua S, Zaky W, Janku F, Penas-Prado M, Weathers SP, Behrang A, Roszik J, Subbiah V. Dual inhibition of BRAF and mTOR in BRAFV600E -mutant pediatric, adolescent, and young adult brain tumors. Cold Spring Harb Mol Case Stud. 2020 08; 6(4). PMID: 32843426; PMCID: PMC7476413.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    21. Aaroe AE, Majd N, Weathers SP, de Groot JF. Potential neurologic and oncologic implications of the novel coronavirus. Neuro Oncol. 2020 07 07; 22(7):1050-1051. PMID: 32296828; PMCID: PMC7184395.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    22. Trifiletti DM, Malouff TD, McGovern SL, Weathers SP, Wang TJC, Lassman AB, Cahill DP, Shih HA, Brown PD. Repeat Radiation in the Brain: Managing Patients With Locally Recurrent Glioma. Semin Radiat Oncol. 2020 07; 30(3):218-222. PMID: 32503786.
      Citations:    Fields:    Translation:Humans
    23. Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D, McGovern S, Paulino AC, Wang C, Woodhouse KD, Yeboa DN, Prabhu SS, Weathers SP, Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol. 2020 Jul-Aug; 5(4):743-745. PMID: 32775785; PMCID: PMC7251361.
      Citations: 6     
    24. Weathers SP, Penas-Prado M, Pei BL, Ling X, Kassab C, Banerjee P, Bdiwi M, Shaim H, Alsuliman A, Shanley M, de Groot JF, O'Brien BJ, Harrison R, Majd N, Kamiya-Matsuoka C, Fuller GN, Huse JT, Chi L, Rao G, Weinberg JS, Lang FF, Sawaya R, Shpall EJ, Rezvani K, Heimberger AB. Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial. Clin Cancer Res. 2020 07 15; 26(14):3565-3577. PMID: 32299815; PMCID: PMC9347965.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    25. de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O'Brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, Zhou S, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger AB. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549. PMID: 31755915; PMCID: PMC7158647.
      Citations: 41     Fields:    Translation:HumansCells
    26. Milbury K, Weathers SP, Durrani S, Li Y, Whisenant M, Li J, Lim B, Weinberg JS, Kesler SR, Cohen L, Bruera E. Online Couple-Based Meditation Intervention for Patients With Primary or Metastatic Brain Tumors and Their Partners: Results of a Pilot Randomized Controlled Trial. J Pain Symptom Manage. 2020 06; 59(6):1260-1267. PMID: 32061834.
      Citations: 3     Fields:    Translation:Humans
    27. Joseph J, Nathenson MJ, Trinh VA, Malik K, Nowell E, Carter K, Weathers SP, Demetri GD, Araujo D, Conley AP. Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor. J Immunother Cancer. 2019 11 08; 7(1):296. PMID: 31703609; PMCID: PMC6842215.
      Citations: 6     Fields:    Translation:HumansCells
    28. Kesler SR, Harrison RA, Petersen ML, Rao V, Dyson H, Alfaro-Munoz K, Weathers SP, de Groot J. Pre-surgical connectome features predict IDH status in diffuse gliomas. Oncotarget. 2019 Nov 05; 10(60):6484-6493. PMID: 31741712; PMCID: PMC6849657.
      Citations: 3     Fields:    
    29. Majd N, Weathers SP, de Groot J. Are we AKT-ually getting closer to making targeted therapy successful in breast cancer brain metastases? Neuro Oncol. 2019 11 04; 21(11):1344-1345. PMID: 31515554; PMCID: PMC6827831.
      Citations:    Fields:    Translation:Humans
    30. Chi AS, Tarapore RS, Hall MD, Shonka N, Gardner S, Umemura Y, Sumrall A, Khatib Z, Mueller S, Kline C, Zaky W, Khatua S, Weathers SP, Odia Y, Niazi TN, Daghistani D, Cherrick I, Korones D, Karajannis MA, Kong XT, Minturn J, Waanders A, Arillaga-Romany I, Batchelor T, Wen PY, Merdinger K, Schalop L, Stogniew M, Allen JE, Oster W, Mehta MP. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol. 2019 Oct; 145(1):97-105. PMID: 31456142; PMCID: PMC7241441.
      Citations: 40     Fields:    Translation:Humans
    31. Acquaye AA, Vera E, Williams LA, Gilbert MR, Weathers SP, Armstrong TS, Pay?n SS. Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews. J Patient Rep Outcomes. 2019 Aug 23; 3(1):58. PMID: 31444579; PMCID: PMC6708028.
      Citations: 1     
    32. Milbury K, Li J, Weathers SP, Shih T, Malliaha S, Li Y, Cohen L. A research protocol for a pilot, randomized controlled trial designed to examine the feasibility of a dyadic versus individual yoga program for family caregivers of glioma patients undergoing radiotherapy. Pilot Feasibility Stud. 2019; 5:95. PMID: 31367462; PMCID: PMC6657047.
      Citations:    
    33. Harrison RA, Anderson MD, Cachia D, Kamiya-Matsuoka C, Weathers SS, O'Brien BJ, Penas-Prado M, Yung WKA, Wu J, Yuan Y, de Groot JF. Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center. Eur J Cancer. 2019 05; 112:83-93. PMID: 30951926.
      Citations: 7     Fields:    Translation:Humans
    34. Zheng S, Alfaro-Munoz K, Wei W, Wang X, Wang F, Eterovic AK, Shaw KRM, Meric-Bernstam F, Fuller GN, Chen K, Verhaak RG, Mills GB, Yung WKA, Weathers SP, de Groot JF. Prospective Clinical Sequencing of Adult Glioma. Mol Cancer Ther. 2019 05; 18(5):991-1000. PMID: 30926639; PMCID: PMC6497568.
      Citations: 5     Fields:    Translation:HumansCells
    35. Hamouda D, Weathers SP, Kumar VA, Nascimento FA. Stroke-like migraine attacks after radiation therapy (SMART) syndrome. Arq Neuropsiquiatr. 2019 03; 77(3):215. PMID: 30970135.
      Citations:    Fields:    Translation:HumansPHPublic Health
    36. Weathers SP, Epner DE. Rookie. J Clin Oncol. 2019 03 20; 37(9):751-753. PMID: 30742562.
      Citations:    Fields:    Translation:Humans
    37. Milbury K, Li J, Weathers SP, Mallaiah S, Armstrong T, Li Y, Bruera E, Cohen L. Pilot randomized, controlled trial of a dyadic yoga program for glioma patients undergoing radiotherapy and their family caregivers. Neurooncol Pract. 2019 Jul; 6(4):311-320. PMID: 31386042; PMCID: PMC6660820.
      Citations: 7     
    38. Harrison RA, Nam JY, Weathers SP, DeMonte F. Intracranial dural, calvarial, and skull base metastases. Handb Clin Neurol. 2018; 149:205-225. PMID: 29307354.
      Citations: 3     Fields:    Translation:Humans
    39. Weathers SS, Gilbert MR. Toward Personalized Targeted Therapeutics: An Overview. Neurotherapeutics. 2017 04; 14(2):256-264. PMID: 27995437; PMCID: PMC5398979.
      Citations: 11     Fields:    Translation:Humans
    40. Srinivasan VM, Ferguson SD, Lee S, Weathers SP, Kerrigan BCP, Heimberger AB. Tumor Vaccines for Malignant Gliomas. Neurotherapeutics. 2017 04; 14(2):345-357. PMID: 28389997; PMCID: PMC5398993.
      Citations: 21     Fields:    Translation:HumansAnimals
    41. Ferguson SD, Xiu J, Weathers SP, Zhou S, Kesari S, Weiss SE, Verhaak RG, Hohl RJ, Barger GR, Reddy SK, Heimberger AB. GBM-associated mutations and altered protein expression are more common in young patients. Oncotarget. 2016 Oct 25; 7(43):69466-69478. PMID: 27579614; PMCID: PMC5342491.
      Citations: 9     Fields:    Translation:HumansCells
    42. Weathers SP, Han X, Liu DD, Conrad CA, Gilbert MR, Loghin ME, O'Brien BJ, Penas-Prado M, Puduvalli VK, Tremont-Lukats I, Colen RR, Yung WKA, de Groot JF. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. J Neurooncol. 2016 09; 129(3):487-494. PMID: 27406589; PMCID: PMC5021605.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    43. Garber ST, Hashimoto Y, Weathers SP, Xiu J, Gatalica Z, Verhaak RG, Zhou S, Fuller GN, Khasraw M, de Groot J, Reddy SK, Spetzler D, Heimberger AB. Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies. Neuro Oncol. 2016 10; 18(10):1357-66. PMID: 27370400; PMCID: PMC5035527.
      Citations: 76     Fields:    Translation:HumansCells
    44. Gatson NT, Weathers SP, de Groot JF. ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma. CNS Oncol. 2016; 5(1):11-26. PMID: 26670466; PMCID: PMC6078156.
      Citations: 8     Fields:    
    45. Weathers SP, de Groot J. VEGF Manipulation in Glioblastoma. Oncology (Williston Park). 2015 Oct; 29(10):720-7. PMID: 26470893.
      Citations: 36     Fields:    Translation:Humans
    46. Weathers SP, Gilbert MR. Current challenges in designing GBM trials for immunotherapy. J Neurooncol. 2015 Jul; 123(3):331-7. PMID: 25577401.
      Citations: 16     Fields:    Translation:Humans
    47. Weathers SP, Gilbert MR. Advances in treating glioblastoma. F1000Prime Rep. 2014; 6:46. PMID: 24991423; PMCID: PMC4047946.
      Citations: 20     
    48. Weathers SP, de Groot J. Resistance to antiangiogenic therapy. Curr Neurol Neurosci Rep. 2014 May; 14(5):443. PMID: 24652451.
      Citations: 8     Fields:    Translation:HumansAnimals
    49. Weathers SP, Kotagal V, Bohnen NI, Chou KL. Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease. Parkinsonism Relat Disord. 2014 Jan; 20(1):13-6. PMID: 24070538; PMCID: PMC3946835.
      Citations: 4     Fields:    Translation:HumansCells
    50. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leuko-Araiosis and cerebral hypoperfusion compared between patients with ischemic vascular dementia and normal elderly volunteers. J Stroke Cerebrovasc Dis. 1992; 2(4):180-8. PMID: 26486828.
      Citations:    
    51. Meyer JS, Terayama Y, Takashima S, Kawamura J, Weathers S. Long-term follow-up of patients with vascular dementia: Bertha memorial lecture, 1992. J Stroke Cerebrovasc Dis. 1992; 2(4):244-8. PMID: 26486845.
      Citations:    
    52. Terayama Y, Meyer JS, Takashima S, Obara K, Weathers S. Comparisons of polio-araiosis and leuko-araiosis in dementias of ischemic vascular and alzheimer types. J Stroke Cerebrovasc Dis. 1993; 3(4):267-75. PMID: 26487464.
      Citations:    
    53. Kawamura J, Meyer JS, Terayama Y, Weathers S. Longitudinal measurement of cerebral perfusion in patients with multi-infarct dementia. J Stroke Cerebrovasc Dis. 1991; 1(4):196-202. PMID: 26486265.
      Citations:    
    54. Guinn GA, Weathers S. Congenital isolation of the subclavian artery in adults. Tex Heart Inst J. 1997; 24(1):58-61; discussion 61-3. PMID: 9068141; PMCID: PMC340382.
      Citations: 1     Fields:    Translation:Humans
    55. Meyer JS, Takashima S, Terayama Y, Obara K, Muramatsu K, Weathers S. CT changes associated with normal aging of the human brain. J Neurol Sci. 1994 May; 123(1-2):200-8. PMID: 8064316.
      Citations: 7     Fields:    Translation:Humans
    56. Kawamura J, Terayama Y, Takashima S, Obara K, Pavol MA, Meyer JS, Mortel KF, Weathers S. Leuko-araiosis and cerebral perfusion in normal aging. Exp Aging Res. 1993 Jul-Sep; 19(3):225-40. PMID: 8223824.
      Citations: 18     Fields:    Translation:Humans
    57. Terayama Y, Meyer JS, Kawamura J, Weathers S. Cognitive recovery correlates with white-matter restitution after head injury. Surg Neurol. 1993 Mar; 39(3):177-86. PMID: 8456379.
      Citations: 2     Fields:    Translation:Humans
    58. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leuko-araiosis and cerebral hypoperfusion compared in elderly normals and Alzheimer's dementia. J Am Geriatr Soc. 1992 Apr; 40(4):375-80. PMID: 1556365.
      Citations: 6     Fields:    Translation:Humans
    59. Terayama Y, Meyer JS, Kawamura J, Weathers S. Role of thalamus and white matter in cognitive outcome after head injury. J Cereb Blood Flow Metab. 1991 Sep; 11(5):852-60. PMID: 1874818.
      Citations: 1     Fields:    Translation:Humans
    60. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. Journal of Neuro-Oncology. 1-8.
    61. Advances in treating glioblastoma. F1000Prime Reports. 6.
    62. Immune checkpoint blockade as a potential therapeutic target. Neuro-Oncology. 18:1357-1366.
    63. VEGF manipulation in glioblastoma. ONCOLOGY (United States). 29:720-727.
    64. Toward Personalized Targeted Therapeutics. Neurotherapeutics. 1-9.
    65. GBM-associated mutations and altered protein expression are more common in young patients. Oncotarget. 7:69466-69478.
    WEATHERS's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (198)
    Explore
    _
    Co-Authors (64)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _